Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-06-30Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.Clinical toxicology (Philadelphia, Pa.) · 2026-06-22Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-29Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy ParticipantsBiological Psychiatry · 2026-04-24Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.Unknown journal · 2025-12-31The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.Unknown journal · 2025-12-25Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.Psychopharmacology · 2025-07-31Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.Unknown journal · 2025-07-30Clinical pharmacology.Unknown journal · 2025-05-22A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Unknown journal · 2025-02-26In vitro and in vivo metabolism of psilocybin’s active metabolite psilocinFrontiers in Pharmacology · 2024-04-28Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.Unknown journal · 2024-01-31Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Unknown journal · 2024-01-10Safety pharmacology of acute psilocybin administration in healthy participantsNeuroscience Applied · 2023-12-31The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studiesJournal of Psychopharmacology · 2023-10-30Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participantsNeuropsychopharmacology · 2023-05-24Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy ParticipantsClinical Pharmacology & Therapeutics · 2022-12-11Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.Neuropsychopharmacology · 2022-02-24Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.Psychopharmacology · 2022-01-24Comparison of subjective, autonomic, and endocrine effects of LSD and psilocybin in healthy subjectsNeuroscience Applied · 2021-12-31Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjectsNeuroscience Applied · 2021-12-31Dosing Psychedelics and MDMA.Unknown journal · 2021-12-31Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.Clinical Pharmacology & Therapeutics · 2021-11-21Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasmaJournal of Chromatography B · 2020-12-06Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.Unknown journal · 2018-09-27Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.Clinical pharmacokinetics · 2017-09-30Alterations of consciousness and mystical-type experiences after acute LSD in humans.Psychopharmacology · 2016-10-06Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.Unknown journal · 2016-05-19